The implementation of the detection of the abuse of 3,4-methylenedioxymethamphetamine and analogues in doping control screening procedures
| Deutscher übersetzter Titel: | Einfuegung des Nachweises von Designerdrogenmissbrauch in die Dopingkontroll-Screeningtests |
|---|---|
| Autor: | Boer, D. de; Graaf, M.L.D. de; Goerter, P.; Maes, R.A.A. |
| Herausgeber: | Schänzer, Wilhelm; Geyer, Hans; Gotzmann, Andrea; Marek-Engelke, U. |
| Erschienen in: | Recent advances in doping analysis (5) : Proceedings of the Manfred Donike Workshop ; 15th Cologne Workshop on Dope Analysis ; 23rd to 28th February 1997 |
| Veröffentlicht: | Köln: Sport u. Buch Strauß (Verlag), 1998, 1998. S. 249-258, Lit., Lit. |
| Format: | Literatur (SPOLIT) |
| Publikationstyp: | Sammelwerksbeitrag |
| Medienart: | Gedruckte Ressource |
| Sprache: | Englisch |
| ISBN: | 3890010164 |
| Schlagworte: | |
| Online Zugang: | |
| Erfassungsnummer: | PU199805301863 |
| Quelle: | BISp |
Abstract des Autors
The abuse of amphetamine designer drugs is in Europe an increasing problem in the field of Drug-Of-Abuse (DOA). lt is a problem which affects not only the society in general, but also sports in particular. Although not in order to improve their sport performance, athletes may use amphetamine designer drugs for recreational reasons. Therefore it would be of interest to implement the detection of the abuse of these designer drugs in doping control screening procedures. Conclusions: 1. Besides the parent compounds several kinds of metabolites can be found in urine after the abuse of 3,4-methylenedioxymethamphetamine and analogues. 2. Depending of the procedure the detection should be focussed on certain metabolites. 3. Current commercial immunoassays are only specific for those metabolites, which still have their amine function, except those which also have both the 3-methoxy and 4-hydroxy substituent. Verf.-Referat